10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001213900-23-084737`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	f10q0923_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 60 Cash Flow Statement 58 Stockholders Equity 39

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.70M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.40M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$99.57M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$142.93M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$512.43K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.04M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.83M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$109.10M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$152.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$47.72K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Total assets	`Assets`	$152.91M	USD	Point-in-time
Total assets	`Assets`	$109.15M	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.86M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.57M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.21M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.42M	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$602.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$636.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-462.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-535.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$166.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$210.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$125.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$111.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$100.73M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$196.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$140.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$109.15M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.91M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Loss per common share diluted	`EarningsPerShareDiluted`	$-4.04	USD	3 Qtrs
Loss per common share diluted	`EarningsPerShareDiluted`	$-4.04	USD	3 Qtrs
Loss per common share diluted	`EarningsPerShareDiluted`	$-1.31	USD	1 Quarter
Loss per common share diluted	`EarningsPerShareDiluted`	$-1.31	USD	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	3 Qtrs
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.47M	shares	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.45M	USD	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.06M	shares	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$86.45M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$30.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$40.06M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.21M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$36.82M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$12.24M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$36.09M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$122.55M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$76.87M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$22.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$38.74M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-38.74M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-22.69M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-122.55M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-76.87M	USD	3 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	3 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.54M	USD	3 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.32M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$827.61K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$3.89M	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-51.71K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-718.42K	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-561.65K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-552.17K	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$72.33K	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-3.90M	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-579.15K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-947.51K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$-681.55K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$690.58K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$3.25M	USD	3 Qtrs
Total other (expense) income net	`NonoperatingIncomeExpense`	$3.45M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-73.63M	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-4.04	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-2.45	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.31	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.73	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.06M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.47M	shares	3 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-73.63M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$33.92M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$32.57M	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-51.71K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-718.42K	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-561.65K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-552.17K	USD	3 Qtrs
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$72.33K	USD	3 Qtrs
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-3.90M	USD	3 Qtrs
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-579.15K	USD	1 Quarter
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-947.51K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	-	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-86.38K	USD	3 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-512.43K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-8.36M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-1.19M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-766.66K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.41M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.64M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.48M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-67.92M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.41M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$57.15M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$38.99M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$60.38M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$99.86M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$21.39M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$42.71M	USD	3 Qtrs
Payment of fees for warrants issued for common stock	`PaymentOfFeesForWarrantsIssuedForCommonStock`	$50.00K	USD	3 Qtrs
Payment of fees for warrants issued for common stock	`PaymentOfFeesForWarrantsIssuedForCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$703.72K	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$1.23M	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.61M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	3 Qtrs
Net increase /(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.92M	USD	3 Qtrs
Net increase /(decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.30M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.40M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.52M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.70M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.40M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$42.52M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.70M	USD	Point-in-time
Share exchange for Pre-funded warrants	`CashLessShareExchangeForPrefundedWarrants`	-	USD	3 Qtrs
Share exchange for Pre-funded warrants	`CashLessShareExchangeForPrefundedWarrants`	$1.45K	USD	3 Qtrs

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$166.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$125.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$111.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$100.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.17M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.93M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$12.30M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.34M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$11.35M	USD	1 Quarter
Share exchange Pre-funded warrants, net of fees	`StockIssuedDuringPeriodValueOther`	$-50.00K	USD	1 Quarter
ATM offering, net	`StockIssuedDuringPeriodValueNewIssues`	$29.58M	USD	1 Quarter
ATM offering, net	`StockIssuedDuringPeriodValueNewIssues`	$13.15M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$595.35K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$300.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$332.92K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$286.18K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$64.80K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$352.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.30M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.00M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-73.63M	USD	3 Qtrs
Balance	`StockholdersEquity`	$166.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$125.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$111.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$100.73M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.